Can Mycoplasma pneumoniae infection cause hemoptysis?

Can Mycoplasma Cause Hemoptysis?

Yes, Mycoplasma pneumoniae can cause hemoptysis, though it is an uncommon and potentially severe complication that typically manifests as diffuse alveolar hemorrhage (DAH) rather than simple blood-streaked sputum.

Clinical Context and Mechanism

While the major CAP guidelines 1 identify M. pneumoniae as one of the most common pathogens in community-acquired pneumonia (particularly in patients <50 years without comorbidities), they do not list hemoptysis as a typical presenting feature. However, when hemoptysis does occur with Mycoplasma infection, it represents a serious complication requiring immediate recognition and treatment 2.

The mechanism appears to be DAH—a life-threatening pulmonary complication where blood fills the alveolar spaces. Case reports demonstrate that this can present dramatically, with patients requiring intubation for airway protection 2. The ACR hemoptysis guidelines 3 note that respiratory infections are among the common causes of hemoptysis in tertiary centers, though they don't specifically highlight atypical pathogens.

Key Clinical Features to Recognize

When Mycoplasma causes hemoptysis, look for:

• Acute onset of significant hemoptysis (can occur within 1-2 days) 2
• Ground glass opacities and interlobular septal thickening on chest CT, suggesting DAH 4
• Multiple blood clots in several lung lobes on bronchoscopy 2
• Positive Mycoplasma IgM (with negative IgG indicating acute infection) 2
• Underlying conditions like sarcoidosis may increase susceptibility 4

Diagnostic Approach

In a patient presenting with hemoptysis:

1. Rule out common causes first: pulmonary embolism, coagulopathy, vasculitis 2
2. Consider atypical infections early, especially in younger patients with acute respiratory symptoms
3. Obtain Mycoplasma serology (IgM and IgG) alongside routine workup
4. Perform bronchoscopy if DAH is suspected based on imaging or clinical severity
5. CT chest will show characteristic ground glass consolidation if DAH is present 4

Treatment Implications

Start appropriate antibiotics early when Mycoplasma-associated hemoptysis is suspected 2. The standard macrolide therapy recommended for M. pneumoniae pneumonia 1 applies:

• Azithromycin or clarithromycin for previously healthy patients
• Doxycycline is an effective alternative (used successfully in the DAH case) 2
• Complete a 10-day course of antibiotics 2

Important Caveats

• This is a rare presentation: In a pediatric hemoptysis series, only 4 of 35 pneumonia cases (11%) were due to Mycoplasma 5, and DAH was not the typical mechanism
• Don't assume all Mycoplasma pneumonia will cause hemoptysis—most cases present with typical atypical pneumonia symptoms (gradual onset cough, pharyngitis, malaise) 1
• Massive hemoptysis from Mycoplasma is exceptional; when it occurs, it demands aggressive management including potential airway protection 2
• Consider co-infections: One case had concurrent rhinovirus, though improvement with antibiotics suggested Mycoplasma as the primary culprit 2

The key clinical pearl: maintain a low threshold for suspecting atypical infections when encountering unexplained hemoptysis or alveolar bleeding, particularly in younger patients without traditional risk factors for hemoptysis 2.